Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
PharmaCyte Biotech, Inc. (NVLX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
SC 13D/A
| Iroquois Capital Management, LLC reports a 5% stake in PharmaCyte Biotech, Inc. |
| 05/12/2023 |
SC 13D/A
| Iroquois Capital Management, LLC reports a 7% stake in PharmaCyte Biotech, Inc. |
| 08/15/2022 |
SC 13D/A
| Iroquois Capital Management, LLC reports a 6.7% stake in PharmaCyte Biotech, Inc. |
| 07/11/2022 |
SC 13D/A
| Iroquois Capital Management, LLC reports a 6.6% stake in PharmaCyte Biotech, Inc. |
| 06/23/2022 |
SC 13D/A
| Iroquois Capital Management, LLC reports a 6.7% stake in PharmaCyte Biotech, Inc. |
| 07/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|